Clinical Trial Update: Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bone marrow-derived stem cell transfer in patients with acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bone marrow-derived stem cells

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED